Article
Top news from across the health care landscape.
Fatigue profiles for patients with multiple sclerosis (MS) are based on severity of fatigue and not on various dimensions, according to The American Journal of Managed Care. The researchers set out to determine whether fatigue profiles for patients with MS are based on various dimensions of fatigue and to see whether there is a single, common, unidimensional factor model of perceived fatigue in patients with MS. Based on their findings, the researchers concluded that fatigue profile solutions are not helpful when it comes to targeting optimal fatigue interventions among patients with MS.
Monitoring pre-discharge opioid use in women after a caesarean delivery could help optimize non-opioid analgesia and reduce opioid use, according to HCP Live. Researchers conducted a prospective cohort study of more than 200 cesarean section (C-section) patients and found that those who reported low opioid use after hospital discharge took on average 44% fewer opioids in the 24 hours before discharge than those who reported higher use. The findings, along with clinical education, could be essential in changing opioid prescribing practices, according to the study authors.
For African men living with HIV who are not virally suppressed, community-based antiretroviral therapy (ART) significantly increased viral suppression compared with clinic-based ART, according to Contagion Live. The study authors note that providers do not need to wait for individuals to demonstrate success on ART before offering them more simplified delivery strategies, therefore, providers should be offering differentiated services for HIV earlier on. Meanwhile, although community-based ART worked overall, it worked especially well for men who faced multiple barriers for clinic-based visits.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa
2 Commerce Drive
Cranbury, NJ 08512